Jasnoor Malhotra
Overview
Explore the profile of Jasnoor Malhotra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
215
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bergerot C, Bergerot P, Philip E, Malhotra J, Castro D, Govindarajan A, et al.
Oncologist
. 2025 Jan;
30(1).
PMID: 39820635
Background: Patients with metastatic renal cell carcinoma (mRCC) experience emotional distress and limited supportive care access. This study assesses a mindfulness app's feasibility, acceptability, and preliminary efficacy in improving emotional...
2.
Ebrahimi H, Dizman N, Meza L, Malhotra J, Li X, Dorff T, et al.
Nat Med
. 2024 Jun;
30(9):2576-2585.
PMID: 38942995
Supplementation with CBM588, a bifidogenic live bacterial product, has been associated with improved clinical outcomes in persons with metastatic renal cell carcinoma (mRCC) receiving nivolumab and ipilimumab. However, its effect...
3.
Bergerot C, Philip E, Malhotra J, Bergerot P, Castro D, Govindarajan A, et al.
J Genet Couns
. 2023 Sep;
33(4):911-915.
PMID: 37697864
We sought to determine racial and ethnic differences in perceptions (quality of communication, expectations, and concerns) of germline or somatic DNA sequencing (genomic profiling). Patients with prostate, urothelial, or kidney...
4.
Bergerot C, Philip E, Govindarajan A, Castro D, Malhotra J, Bergerot P, et al.
Clin Genitourin Cancer
. 2023 Jun;
21(6):626-630.e3.
PMID: 37391301
Background: We explored changes in perceptions of cure among patients with genitourinary (GU) cancers starting Immune checkpoint inhibitors (ICIs) therapy. Materials And Methods: This longitudinal study assessed patients before starting...
5.
Chehrazi-Raffle A, Muddasani R, Dizman N, Hsu J, Meza L, Zengin Z, et al.
JCO Precis Oncol
. 2023 Apr;
7:e2200543.
PMID: 37027813
Purpose: Circulating tumor DNA (ctDNA) has been validated across multiple indications in the adjuvant and surveillance settings. We evaluated whether targeted digital sequencing (TARDIS) may distinguish a partial response (PR)...
6.
Meza L, Zengin Z, Salgia S, Malhotra J, Karczewska E, Dorff T, et al.
Oncologist
. 2023 Mar;
28(9):e748-e755.
PMID: 36971500
Background: Vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have had a transformative impact on morbidity and mortality. However, the long-term impact of vaccination on patients with genitourinary cancers...
7.
Bergerot C, Malhotra J, Bergerot P, Philip E, Castro D, Hsu J, et al.
Oncologist
. 2023 Mar;
28(6):494-500.
PMID: 36917626
Background: There is a lack of consensus regarding the optimal method of assessing health-related quality of life (HR-QOL) among patients with metastatic renal cell carcinoma (mRCC). This study explored the...
8.
Zengin Z, Govindarajan A, Salgia N, Sayegh N, Tripathi N, Muddasani R, et al.
Eur Urol Oncol
. 2023 Jan;
6(4):447-450.
PMID: 36609061
Stereotactic body radiation therapy (SBRT) has been shown to be safe and effective for delaying systemic treatment change among patients with metastatic renal cell carcinoma (mRCC). In this study, we...
9.
Chawla N, Sayegh N, Tripathi N, Govindarajan A, Zengin Z, Phillip E, et al.
Clin Genitourin Cancer
. 2022 Dec;
21(1):69-75.
PMID: 36509613
Background: Recently data suggest that telomerase reverse transcripatase (TERT) promoter mutations portend superior outcomes with immune checkpoint inhibitor (ICI) therapy in mUC. In our retrospective analysis from 2 tertiary cancer...
10.
Castro D, Zengin Z, Malhotra J, Bergerot C, Meza L, Dizman N, et al.
Cancer Invest
. 2022 Oct;
41(1):70-76.
PMID: 36239609
Since the approval of the COVID-19 vaccines, their safety and efficacy has been widely demonstrated in patients with cancer. However, there remain patients with reservations regarding vaccination. We aimed to...